Obes Res Clin Pract 2025;19:77-9.ArticlePubMed 99
utilized claims records extracted from the National Health Insurance Research Database (NHIRD) and suggested that patients with diabetes who underwent GLP-1 RA therapy experienced a significant reduction in the risk of anxiety 20
Liraglutide and cardiovascular outcomes in type 2 diabetes
GLP-1 receptor agonists are medications that mimic this hormone, triggering a cascade of metabolic signals: they slow gastric emptying (keeping you full longer), reduce appetite through hypothalamic signaling, enhance insulin secretion in response to meals, and improve glucose homeostasis
GLP-1 also affects the brain, signaling satiety and reducing appetite, which is why its often targeted in weight-management therapies, Dr
For those considering a switch between delivery methods, our guide on tirzepatide tablets versus injections covers the tradeoffs in detail